CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
Authors
AH Turaj
AJ Olszewski
+47 more
Andrew J. Davies
AW Chan
B Coiffier
BD Cheson
BD Cheson
C Gisselbrecht
C Stolz
Diana Fernando
Gareth Griffiths
Graham P. Collins
H Akiba
HA Burris
I Mellman
JE Willoughby
Joke Dhondt
Joshua Caddy
K Sugita
Karan Vadher
Keira Fines
Kim M. Linton
LA Gravestein
LA Vitale
Laura E. Rogers
Liz Rossiter
Louise Stanton
LZ He
M Pfreundschuh
ME Polak
MJ Glennie
P Ramakrishnan
Peter W. M. Johnson
Q Gong
R Marcus
RA Clynes
RA van Lier
SA Beers
Sean H. Lim
SH Lim
SH Swerdlow
SL Buchan
SM Ansell
TF Rowley
VY Taraban
VY Taraban
VY Taraban
VY Taraban
Y Xiao
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 11/12/2019